Latest News & Updates

Breaking News

  • 1 hour ago

  • Pharma Now Editorial Team

Symeres Appoints Henning Steinhagen as CEO to Lead Next Phase of Global Expansion
Breaking News
Biocon Pharma Gains Health Canada Approval for Micafungin Injection 50 mg and 100 mg

Pharma Now Editorial Team

Other trending news you may like to read

Symeres Appoints Henning Steinhagen as CEO to Lead Next Phase of Global Expansion

Symeres names Henning Steinhagen CEO, signalling a strategic push for global growth across its CDMO portfolio.

Pharma Now Editorial Team

Pharma Now

Biocon Pharma Gains Health Canada Approval for Micafungin Injection 50 mg and 100 mg

Biocon Pharma secures Health Canada approval for Micafungin for Injection USP in 50 mg and 100 mg strengths, expanding its sterile injectable generics presence in Canada.

Pharma Now Editorial Team

Pharma Now

FUJIFILM Biosciences and NextCell Launch Platform to Standardize Regenerative Medicine Manufacturing

FUJIFILM Biosciences and NextCell launch a joint platform targeting MSC variability, immunocompatibility, and GMP workflow gaps in ATMP manufacturing.

Pharma Now Editorial Team

Pharma Now

Bristol Myers Squibb Gains EU Approval for Sotyktu as First TYK2 Inhibitor in Psoriatic Arthritis

BMS secures EU approval for Sotyktu in psoriatic arthritis, the first TYK2 inhibitor cleared for the indication, raising immediate questions on API sourcing and GMP compliance.

Pharma Now Editorial Team

Pharma Now